{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:13:03Z","timestamp":1791162783878,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":6119,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.micinf.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,1,28]],"date-time":"2007-01-28T07:02:38Z","timestamp":1169967758000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?"],"prefix":"10.1016","volume":"9","author":[{"given":"Suman","family":"Rijal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Yardley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Decuypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basudha","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonne","family":"De Doncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2007.01.009_bib1","series-title":"The Leishmaniasis and Leishmania\/HIV Coinfections","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.micinf.2007.01.009_bib2","unstructured":"World Health Organization, Control of the Leishmaniases. Report of a WHO Expert Committee, Geneva. World Health Organization Technical Reports 793 (1990) 1\u2013158."},{"key":"10.1016\/j.micinf.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micinf.2007.01.009_bib4","unstructured":"ICMR, Minutes of the Expert Group Meeting on Drug Therapy in Leishmaniasis, New Delhi, 2000."},{"key":"10.1016\/j.micinf.2007.01.009_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2007.01.009_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micinf.2007.01.009_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micinf.2007.01.009_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2007.01.009_bib9","first-page":"837","article-title":"Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation, East Mediterr","volume":"9","author":"Abdo","year":"2003","journal-title":"Health J."},{"key":"10.1016\/j.micinf.2007.01.009_bib10","series-title":"Epidemiology and Disease Control Division","article-title":"The Annual Internal Assessment of Malaria and Kala-azar Control Activities","author":"EDCD","year":"2002"},{"key":"10.1016\/j.micinf.2007.01.009_bib11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/382049","article-title":"Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex","volume":"189","author":"Tintaya","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2007.01.009_bib12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","article-title":"American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility?","volume":"194","author":"Yardley","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2007.01.009_bib13","first-page":"131","article-title":"Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar","volume":"18","author":"Das","year":"2005","journal-title":"Natl. Med. J. India"},{"key":"10.1016\/j.micinf.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.micinf.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.47.5.1529-1535.2003","article-title":"The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis","volume":"47","author":"Carter","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in\u00a0vitro and in vivo experimental models","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micinf.2007.01.009_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2007.01.009_bib18","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1074\/jbc.M005423200","article-title":"Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani","volume":"276","author":"Shaked-Mishan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micinf.2007.01.009_bib19","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micinf.2007.01.009_bib20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","article-title":"Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages","volume":"50","author":"Mookerjee","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/AAC.44.9.2406-2410.2000","article-title":"Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood","volume":"44","author":"Rais","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micinf.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1179\/000349803235001714","article-title":"Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells","volume":"97","author":"Dasgupta","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.micinf.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1128\/IAI.70.12.6589-6591.2002","article-title":"Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasi","volume":"70","author":"Kocyigit","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2007.01.009_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI114009","article-title":"Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis","volume":"83","author":"Murray","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micinf.2007.01.009_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/IAI.68.1.288-293.2000","article-title":"Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis","volume":"68","author":"Murray","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis","volume":"182","author":"Murray","year":"2000","journal-title":"J. Infect. Dis."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645790700041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645790700041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:19:36Z","timestamp":1761142776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645790700041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S128645790700041X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2007.01.009","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2007.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}